Table 1 Baseline characteristics of the study subjects
Total (n = 375) | Male (n = 242) | Female (n = 133) | |
|---|---|---|---|
Age, years | 66.8 ± 13.6 | 64.6 ± 13.6 | 70.5 ± 12.2 |
BMI, kg/m2 | 22.0 ± 3.5 | 22.3 ± 3.4 | 21.5 ± 3.7 |
HD vintage, months | 65.3 ± 75.2 | 58.7 ± 69.1 | 77.6 ± 84.3 |
Single-pool Kt/V | 1.4 ± 0.3 | 1.3 ± 0.2 | 1.6 ± 0.3 |
Hb, g/dl | 10.8 ± 1.1 | 10.8 ± 1.1 | 10.7 ± 1.0 |
Ferritin, ng/ml | 89.6 ± 86.7 | 84.7 ± 87.9 | 97.0 ± 82.7 |
Albumin, g/dl | 3.6 ± 0.3 | 3.7 ± 0.4 | 3.6 ± 0.3 |
CRP, mg/dl | 0.6 ± 1.5 | 0.6 ± 1.4 | 0.6 ± 1.8 |
Intact PTH, pg/ml | 152.1 ± 164.7 | 146.9 ± 157.1 | 162.1 ± 178.8 |
Phosphorus, mg/dl | 5.3 ± 1.3 | 5.3 ± 1.4 | 5.2 ± 1.2 |
Calcium, mg/dl | 8.7 ± 0.7 | 8.6 ± 0.8 | 8.7 ± 0.6 |
ALP, U/l | 245.4 ± 99.4 | 231.9 ± 84.7 | 268.3 ± 117.3 |
TSAT, % | 21.9 ± 11.3 | 22.8 ± 11.9 | 20.1 ± 9.9 |
Systolic BP, mmHg | 149.6 ± 22.5 | 150.5 ± 22.8 | 148.2 ± 22.0 |
Diastolic BP, mmHg | 78.0 ± 13.9 | 79.5 ± 14.5 | 75.4 ± 12.5 |
History of CVD | 11.2 % | 12.4 % | 8.3 % |
ESA dosage, IU/week | 5444 ± 3538 | 5473 ± 3700 | 5392 ± 3238.6 |
ERI, IU/kg/week/g/dl | 10.5 ± 7.8 | 9.6 ± 7.3 | 12.1 ± 8.4 |